Inogen, Inc. (INGN)
6.27
-0.02
(-0.40%)
USD |
NASDAQ |
Oct 16, 13:31
Inogen SG&A Expense (TTM) : 167.42M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 167.42M |
| March 31, 2026 | 167.18M |
| December 31, 2025 | 165.07M |
| September 30, 2025 | 167.62M |
| June 30, 2025 | 169.65M |
| March 31, 2025 | 171.57M |
| December 31, 2024 | 175.65M |
| September 30, 2024 | 184.30M |
| June 30, 2024 | 181.78M |
| March 31, 2024 | 179.11M |
| December 31, 2023 | 182.35M |
| September 30, 2023 | 161.79M |
| June 30, 2023 | 167.20M |
| March 31, 2023 | 168.75M |
| December 31, 2022 | 164.67M |
| September 30, 2022 | 175.38M |
| June 30, 2022 | 164.43M |
| March 31, 2022 | 155.90M |
| December 31, 2021 | 150.67M |
| September 30, 2021 | 146.00M |
| June 30, 2021 | 139.91M |
| March 31, 2021 | 137.18M |
| December 31, 2020 | 136.12M |
| September 30, 2020 | 135.83M |
| June 30, 2020 | 136.94M |
| Date | Value |
|---|---|
| March 31, 2020 | 141.73M |
| December 31, 2019 | 142.67M |
| September 30, 2019 | 144.11M |
| June 30, 2019 | 147.86M |
| March 31, 2019 | 143.93M |
| December 31, 2018 | 133.66M |
| September 30, 2018 | 120.80M |
| June 30, 2018 | 107.94M |
| March 31, 2018 | 97.08M |
| December 31, 2017 | 88.33M |
| September 30, 2017 | 81.44M |
| June 30, 2017 | 76.36M |
| March 31, 2017 | 71.36M |
| December 31, 2016 | 69.33M |
| September 30, 2016 | 67.37M |
| June 30, 2016 | 63.53M |
| March 31, 2016 | 61.22M |
| December 31, 2015 | 57.03M |
| September 30, 2015 | 53.41M |
| June 30, 2015 | 49.15M |
| March 31, 2015 | 44.92M |
| December 31, 2014 | 42.03M |
| September 30, 2014 | 39.35M |
| June 30, 2014 | 37.15M |
| March 31, 2014 | 26.88M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Inspire Medical Systems, Inc. | 620.30M |
| Stryker Corp. | 8.782B |
| Zimmer Biomet Holdings, Inc. | 3.433B |
| Enovis Corp. | 1.081B |
| Edwards Lifesciences Corp. | 2.201B |